Johns Hopkins Medicine: Immunotherapy Combination May Benefit Patients With Transplanted Kidneys and Advanced Skin Cancers
March 01, 2024
March 01, 2024
BALTIMORE, Maryland, March 1 (TNSres) -- Johns Hopkins Medicine issued the following news release:
People who have had a kidney transplant are at high risk for developing skin cancers. New research directed by investigators from the Johns Hopkins Kimmel Cancer Center is exploring the best combination of treatments to target skin cancers while preserving the transplanted organs.
Now, they report results from a clinical trial testing a novel drug combination designed to s . . .
People who have had a kidney transplant are at high risk for developing skin cancers. New research directed by investigators from the Johns Hopkins Kimmel Cancer Center is exploring the best combination of treatments to target skin cancers while preserving the transplanted organs.
Now, they report results from a clinical trial testing a novel drug combination designed to s . . .